November 27, 2017

November 21, 2017

November 20, 2017

The Texas Drug Utilization Review Board met recently to make recommendations about clinical prior authorizations and the preferred drug list.

November 13, 2017

A monthly update of the crosswalk identifying relationships between National Drug Codes (NDC) and Medicaid payable Healthcare Common Procedure Coding System (HCPCS) codes.

November 10, 2017

A quarterly update of the drug labeler file identifying participation in the CMS Drug Medicaid Rebate Program.

November 9, 2017

November 8, 2017

November 6, 2017

Beginning Jan. 15, claims for the payment of items and services ordered, referred or prescribed, must contain the National Provider Identifier (NPI) of the physician or other professional who ordered, referred or prescribed the items or services. 

October 31, 2017

October 27, 2017

October 13, 2017

A monthly update of the crosswalk identifying relationships between National Drug Codes (NDC) and Medicaid payable Healthcare Common Procedure Coding System (HCPCS) codes.

October 12, 2017

Agenda items are now available for the next quarterly meeting of the Drug Utilization Review (DUR) Board.

October 6, 2017

The July 27, 2017, Texas Medicaid Preferred Drug List (PDL) has been revised, effective October 2, 2017.

Pharmacy providers should expect a delay in state payment because of the upcoming federal bank holiday.

October 3, 2017

Preferred drugs are medications recommended by the Texas Drug Utilization Review Board. The Texas Preferred Drug List is published every January and July.

Pages